摘要 |
<p>The present invention relates to multicyclic compounds that mediate enzymatic activity. These compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including for example, neurodegenerative diseases, inflammation, ischemia, and cancer.</p> |